level-one heading

プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Megan M.に依頼

United States

プロフィール概要

I have extensive research experience in multiple fields, including virology, neurovirology, bioinformatics, microbiology, immunology, clinical research, vaccine trials, endocrinology, and oncology. I am experienced with data and sequence analysis, meta-analyses, and data presentation. I have 6+ years of editing experience with specialization in copy editing and consistency (grammar, spelling, word/phrasing choices, formatting, and data presentation), content, clarity, flow, and organization. I enjoy helping others organize and present their research in multiple formats, including written, poster presentations, and slides for speaking engagements/meetings, with an aim of helping your work impact your chosen target audience. Additionally, I have experience with preparing, writing, and editing proposals and funding requests/applications.

専門分野

• ★ Biology/Life Sciences
• ★ Virology
• ★ Bioinformatics
• ☆ Evolutionary Biology
• ☆ Microbiology
• ☆ Biostatistics
• ☆ Zoology
• ☆ Molecular Evolution
• ☆ Meta-Analysis
• ☆ Vaccine Development
• ☆ Clinical Trials
• ☆ Oncology
• ☆ Tropical Medicine
• ☆ Neuropathology
• ☆ Public Health
• ☆ Epidemiology
• ☆ Medical Sciences

サービス

• Writing
• Research
• Consulting
• Data & AI
• Product Development

職務経験

Lecturer

The Ohio State University

1月 2018 - 現在

Contract Editor

American Journal Experts

7月 2014 - 現在

Post-doctoral researcher

The Ohio State University

5月 2012 - 9月 2014

Contract Editor

Sarkis Science Editing

1月 2009 - 12月 2010

Instructor

Our Lady of Holy Cross College

9月 2003 - 12月 2004

Medical Research Specialist

Tulane University Primate Research Center

6月 2001 - 6月 2004

Research Assistant

The Ohio State University

8月 1998 - 8月 2000

Lab Manager

The Rogosin Institute

10月 1996 - 8月 1998

学歴

PhD

Harvard University

7月 2004 - 5月 2012

MSPH

tulane university

8月 2000 - 12月 2001

BS

The Ohio State University

9月 1992 - 6月 1996

認定資格

• 認定資格の詳細は未入力です。

出版物

JOURNAL ARTICLE

Mefford ME, Kunstman K, Wolinsky SM, Gabuzda D(2015). Bioinformatic analysis of neurotropic HIV envelope sequences identifies polymorphisms in the gp120 bridging sheet that increase macrophage-tropism through enhanced interactions with CCR5 . Virology.

Yen PJ, Mefford ME, Hoxie JA, Williams KC, Desrosiers RC, Gabuzda D(2014). Identification and characterization of a macrophage-tropic SIV envelope glycoprotein variant in blood from early infection in SIVmac251-infected macaques . Virology.

Mates JM, Kumar SB, Bazan J, Mefford M, Voronkin I, Handelman S, Mwapasa V, Ackerman W, Janies D, Kwiek JJ(2013). Genotypic and phenotypic heterogeneity in the U3R region of HIV type 1 subtype C . AIDS research and human retroviruses.

Holman AG, Mefford ME, O'Connor N, Gabuzda D(2010). HIVBrainSeqDB: a database of annotated HIV envelope sequences from brain and other anatomical sites . AIDS research and therapy.

Haim H, Si Z, Madani N, Wang L, Courter JR, Princiotto A, Kassa A, DeGrace M, McGee-Estrada K, Mefford M, et al.(2009). Soluble CD4 and CD4-mimetic compounds inhibit HIV-1 infection by induction of a short-lived activated state . PLoS pathogens.

Mefford ME, Gorry PR, Kunstman K, Wolinsky SM, Gabuzda D(2008). Bioinformatic prediction programs underestimate the frequency of CXCR4 usage by R5X4 HIV type 1 in brain and other tissues . AIDS research and human retroviruses.

Ancuta P, Kamat A, Kunstman KJ, Kim EY, Autissier P, Wurcel A, Zaman T, Stone D, Mefford M, Morgello S, et al.(2008). Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients . PloS one.

Gorry PR, Dunfee RL, Mefford ME, Kunstman K, Morgan T, Moore JP, Mascola JR, Agopian K, Holm GH, Mehle A, et al.(2007). Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygote . Virology.

Lederman MM, Veazey RS, Offord R, Mosier DE, Dufour J, Mefford M, Piatak M, Lifson JD, Salkowitz JR, Rodriguez B, et al.(2004). Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5 . Science (New York, N.Y.).

Smith SM, Mefford M, Sodora D, Klase Z, Singh M, Alexander N, Hess D, Marx PA(2004). Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect . AIDS (London, England).

Ramsburg E, Rose NF, Marx PA, Mefford M, Nixon DF, Moretto WJ, Montefiori D, Earl P, Moss B, Rose JK(2004). Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol . Journal of virology.

Veazey RS, Klasse PJ, Ketas TJ, Reeves JD, Piatak M, Kunstman K, Kuhmann SE, Marx PA, Lifson JD, Dufour J, et al.(2003). Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection . The Journal of experimental medicine.

Eaton KA, Mefford M, Thevenot T(2001). The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice . Journal of immunology (Baltimore, Md. : 1950).

Eaton KA, Kersulyte D, Mefford M, Danon SJ, Krakowka S, Berg DE(2001). Role of Helicobacter pylori cag region genes in colonization and gastritis in two animal models . Infection and immunity.

Eaton KA, Mefford ME(2001). Cure of Helicobacter pylori infection and resolution of gastritis by adoptive transfer of splenocytes in mice . Infection and immunity.